FDCBSEFDC LIMITED· Pharmaceuticals & BiotechnologyHighNeutral
Announced Wed, 5 Aug, 2026 · 15:04 IST

FDC Q1 FY27: revenue up 2.4%, PAT grows 8% to Rs 132 cr

FDC · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-4.8%Reaction day
₹403.00
prior close
₹391.15
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.3%-6.1% vs market
Pharmaceuticals peers, median of 165sector-0.0%-4.8% vs sector

On the reaction day the stock moved 6.1 pts less than Nifty Microcap 250 and 4.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.4
10m
-0.8
15m
-1.5
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-4.8+1.3-6.1-0.0-4.8
Next day
-8.0+1.6-9.7+0.2-8.3
2d
-8.2+1.7-9.9+0.4-8.6
3d
-11.4+1.6-13.0+1.1-12.5
4d
-10.4+1.5-11.8+1.2-11.6
5d
-12.0+1.8-13.8+1.0-13.0
1w
-11.7+2.1-13.8+0.5-12.2
15d
-13.4+3.2-16.6+0.2-13.6
1m
-14.9+3.7-18.6+1.7-16.6
2m
-18.1+1.1-19.2+1.2-19.3
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

FDC Limited Q1 FY27 standalone revenue rose 2.4% to Rs 555.1 cr; PAT up 8% at Rs 132 cr. EPS at Rs 8.11 vs Rs 7.51. Total income Rs 702.4 cr. Consolidated revenue Rs 667.7 cr, PAT Rs 132.5 cr. Board approved up to Rs 45 lakh for 26% stake in Netra Green Energy (Sunsure Energy subsidiary) for captive solar project at Roha API plant. Auditors gave an unmodified review.

Likely market impact

Modest revenue growth, steady profit uptick, and small solar power investment. Clean audit. Stable quarter for shareholders.